STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer

STAAR Surgical has appointed Warren Foust as its new President and Chief Executive Officer and a member of the Board of Directors, effective August 4, 2026. Mr. Foust, an internal candidate, previously served as the company's Chief Operating Officer and has been Interim Co-CEO since February 2026. Concurrently, Deborah Andrews, who served as Interim Co-CEO with Mr. Foust, will continue in her role as Chief Financial Officer and has been appointed Executive Vice President.

Key Details

• CEO Appointment: Warren Foust's appointment as President and CEO is effective August 4, 2026. He joined the company in April 2023 as COO.
• CEO Compensation: Mr. Foust will receive an annual base salary of $730,000 and a target annual bonus of 100% of his base salary. He was also granted a significant equity package of RSUs and stock options, including performance-based options with stock price hurdles at $50, $75, and $100 per share.
• Other Executive Changes: Deborah Andrews will cease her Interim Co-CEO duties and continue as Chief Financial Officer, adding the title of Executive Vice President, effective August 4, 2026.